Growth Metrics

Staar Surgical (STAA) Return on Equity (2016 - 2026)

Staar Surgical (STAA) has disclosed Return on Equity for 16 consecutive years, with 0.27% as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Return on Equity fell 23.0% year-over-year to 0.27%, compared with a TTM value of 0.27% through Jan 2026, down 23.0%, and an annual FY2026 reading of 0.24%, down 20.0% over the prior year.
  • Return on Equity was 0.27% for Q1 2026 at Staar Surgical, up from 0.3% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.25% in Q2 2022 and bottomed at 0.3% in Q3 2025.
  • Average Return on Equity over 5 years is 0.04%, with a median of 0.1% recorded in 2022.
  • The sharpest move saw Return on Equity grew 22bps in 2022, then crashed -48bps in 2025.
  • Year by year, Return on Equity stood at 0.11% in 2022, then surged by 84bps to 0.2% in 2023, then tumbled by -120bps to 0.04% in 2024, then tumbled by -649bps to 0.3% in 2025, then grew by 10bps to 0.27% in 2026.
  • Business Quant data shows Return on Equity for STAA at 0.27% in Q1 2026, 0.3% in Q3 2025, and 0.3% in Q2 2025.